Alaa Rahhal1, Fadi Khir2, Mohammad Adam2, Amer Aljundi3, Mohammed Khalil Mohsen4, Jassim Al-Suwaidi4. 1. Pharmacy Department, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar. arahhal1@hamad.qa. 2. Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar. 3. Pharmacy Department, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar. 4. Cardiology and Cardiovascular Surgery Department, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Abstract
BACKGROUND: Combined oral contraceptive pills are associated with an established risk for venous thrombosis; however, their risk for arterial thrombosis remains uncertain, especially with the development of low dose new generations of combined oral contraceptive. Arterial thrombosis is less likely to occur with the use of oral contraceptive pills in the absence of cardiovascular risk factors. CASE PRESENTATION: We report a 35-year old female with no cardiovascular risk factors who presented with thrombotic anterior wall myocardial infarction 6 months after using a third generation low dose combined oral contraceptive pills (Marvelon; ethinylestradiol 30 mcg and desogestrel 150 mcg). CONCLUSION: Third generation low dose combined oral contraceptives may lead to myocardial infarction in young women, even in the absence of other cardiovascular risk factors.
BACKGROUND: Combined oral contraceptive pills are associated with an established risk for venous thrombosis; however, their risk for arterial thrombosis remains uncertain, especially with the development of low dose new generations of combined oral contraceptive. Arterial thrombosis is less likely to occur with the use of oral contraceptive pills in the absence of cardiovascular risk factors. CASE PRESENTATION: We report a 35-year old female with no cardiovascular risk factors who presented with thrombotic anterior wall myocardial infarction 6 months after using a third generation low dose combined oral contraceptive pills (Marvelon; ethinylestradiol 30 mcg and desogestrel 150 mcg). CONCLUSION: Third generation low dose combined oral contraceptives may lead to myocardial infarction in young women, even in the absence of other cardiovascular risk factors.
Entities:
Keywords:
Case report; Myocardial infarction; Oral contraceptives
Authors: Gaspar Del Rio-Pertuz; Juthipong Benjanuwattra; Saif El Nawaa; Ankush Lahoti; Scott Shurmur Journal: J Investig Med High Impact Case Rep Date: 2022 Jan-Dec